MarginsXMarginsX
Home › Markets › Health Care › GRDX

GridAI Technologies Corp. (GRDX)

GRDX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$3.30
-11.76% on the day
Market cap
$23.5M
Nano cap
Revenue · 2025
$36K
Prior year not contiguous
Net income · 2025
-$6.4M
-17634.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1604191/000110465926054106/0001104659-26-054106-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerGRDX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2016
SEC CIK0001604191
SEC industry codeElectric & Other Services Combined
Incorporated inDE

Financials · 2025

LineValue
Revenue$36K
Net income-$6.4M
Operating income-$7.1M
Net margin-17634.4%
Operating margin-19540.0%
Revenue growthNo prior-year revenue to compare
Cash$900K
Total assets$48.6M
P/E (computed)Net income was not positive
P/S (computed)649.2×

Warning signs

Cash runway
2.0 months
$1.4M cash at June 30, 2026
Share count, 1 year
+348.9%
2025-08-14 to 2026-08-31 · +5882.3% over 3 years
Going-concern doubt
Yes
10-Q filed August 21, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the Company's ability to continue as a going concern one year from the date these financial statements are issued."
10-Q 2026-08-21
Cash and burn$1.4M cash; operating cash flow -$2.0M a quarter.Report 2026-06-30
Shares outstanding7,131,123 (2026-08-31); 4,765,729 a year earlier; 7,152,204 three years earlier. 1y figure adjusted for splits (1-for-3 overall); 3y figure adjusted for splits (1-for-60 overall).Cover page 2026-08-31
Reverse splits, 3 years2; latest 1-for-3 on 2025-08-18Source 2025-08-18
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-04-28
AuditorMacias Gini & O'Connell LLP, Irvine, California, United StatesPCAOB Form AP 2026-05-13
Late filings, 12 months4 NT noticesNT 10-Q 2026-08-14
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$86K-$13.0M-$1.5M$1.4M$1.7MNeeds four quarters10-Q/A 2026-09-18
Q1 2026
2026-03-31
$38K-$3.4M-$1.8M$386K$2.4MNeeds four quarters10-Q 2026-05-27
Q4 2025
2025-12-31
Not filed-$3.0M-$4.0M$900K$2.0M$36K10-K 2026-05-01
Q3 2025
2025-09-30
Not filed-$1.2M-$856K$2.5MNo debt tagsNeeds four quarters10-Q 2025-11-19
Q2 2025
2025-06-30
Not filed-$998K-$55K$4KNo debt tagsNeeds four quarters10-Q 2025-08-14
Q1 2025
2025-03-31
Not filed-$1.3M-$819K$59KNo debt tagsNeeds four quarters10-Q 2025-05-15
Q4 2024
2024-12-31
Not filed-$12.2M-$172K$163KNo debt tagsNeeds four quarters10-K 2026-05-01
Q3 2024
2024-09-30
Not filed-$2.6M-$1.8M$367KNo debt tagsNeeds four quarters10-Q 2025-11-19

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentPOS AM2026-10-28
Latest annual report10-K2026-05-01
Latest quarterly / interim10-Q/A2026-09-18
Latest current report
FORM 8-K
8-K2026-10-30
Latest proxyPRE 14A2025-08-26

Source: SEC EDGAR submissions feed, 767 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-24.0%
1 month-17.8%
3 months-1.3%
Year to date-19.7%
1 year+1.9%
From 52-week high-45.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
FLNAFilana Therapeutics Inc.$0.4700+10.56%$23.6M
BYSIBeyondSpring Inc.$0.5788-3.73%$23.8M
IXHLIncannex Healthcare Inc.$1.93-2.03%$24.2M
RNAZTransCode Therapeutics Inc.$1.35-1.46%$22.9M
IMMPImmutep Limited$3.40-2.30%$25.1M
CRVOCervoMed Inc.$1.67-1.18%$25.3M
ABVCABVC BioPharma Inc.$0.9400+3.30%$25.4M
EDSAEdesa Biotech Inc. Common Shares$1.89-2.58%$25.5M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier